Learn More
BACKGROUND Lipid-lowering therapeutics, particularly HMG Co-A reductase inhibitors, can be beneficial in primary and secondary cardiovascular prevention. The Canadian population frequently uses these medications but the manner in which they are used in community-based practice is unknown. OBJECTIVES To assess the patient characteristics associated with(More)
This paper presents a novel maximum power point tracking (MPPT) algorithm that is optimized for a photovoltaic (PV) system under rapid changes in environmental conditions. This new approach employs the dividing rectangles (DIRECT) algorithm to improve both the speed and accuracy simultaneously, which is the contradiction in conventional methods such as(More)
8046 Background: BAY 43-9006 is a multikinase inhibitor. The RAS/BRAF/MEK/MAPK pathway (pw) is a major pw for transmitting extracellular growth factor signals to the nucleus. Activating mutations in any of the pw kinases would be expected to result in uncontrolled cell proliferation. Approximately 60% of melanomas carry B-Raf mutations. The primary trial(More)
  • 1